IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
IM Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026
$1.50+0.11 (+7.91%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | After market close | $7.60M | $0.47 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 12, 2025 | Before market open | – | $0.09 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | Before market open | $13.30M | $-0.32 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 14, 2024 | Before market open | $14.80M | $-0.23 | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 14, 2023 | Before market open | $13.20M | $-0.26 | – |
Press releases
Announcements IM Cannabis filed with the SEC
Cannabis Announces Closing of the Sale of IMC Holdings and Its
EX-99.1 to Form 6-K
VANCOUVER and GLIL YAM, Israel, September 28,
EX-99.1 to Form 6-K
Closing of US$1.31 Million Registered Direct Offering of Common Shares
EX-99.1 to Form 6-K
Pricing of US$1.31 Million Registered Direct Offering of Common Shares
EX-99.1 to Form 6-K
Compliance with Nasdaq Minimum Bid Price Requirement
EX-99.1 to Form 6-K
Non-Binding Agreement to Acquire 51% of Space
EX-99.1 to Form 6-K
IM Cannabis Shares Commence Trading on 30:1
EX-99.1 to Form 6-K
IM Cannabis Announces Intention to Complete
EX-99.1 to Form 6-K
IM Cannabis Enters into Agreement to Sell IMC Holdings and European-
EX-99.1 to Form 6-K
UNAUDITED PRO FORMA INTERIM CONDENSED FINANCIAL INFORMATION
EX-99.2 to Form 6-K
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
EX-99.3 to Form 6-K
IM Cannabis Provides Corporate Update
EX-99.1 to Form 6-K
US$225,000 of Gross Proceeds in Convertible Note Financing
EX-99.1 to Form 6-K
IM Cannabis Announces Form F-3 Resale Registration Statement Filing
EX-99.1 to Form 6-K
Cannabis Corp. Announces First Quarter 2026 Financial Results
EX-99.1 to Form 6-K
As of March 31, 2026
EX-99.2 to Form 6-K
NOTE REGARDING THE COMPANY’S ACCOUNTING PRACTICES
EX-99.3 to Form 6-K
US$550,000 of Gross Proceeds in Convertible Note Financings
EX-99.1 to Form 6-K
IMC Announces Receipt of Nasdaq Minimum Bid Price Notification
EX-99.1 to Form 6-K
IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134%
EX-99.1 to Form 6-K
IMC Announces a Strategic Entry to the Cyber Drone Interception and
EX-99.1 to Form 6-K
IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements
EX-99.1 to Form 6-K
IM Cannabis Appoints Asi Levi as Chief Financial Officer
EX-99.1 to Form 6-K
510 Burrard Street, 3rd Floor
EX-99.1 to Form 6-K
IM Cannabis Reports Third Quarter 2025 Financial Results
EX-99.1 to Form 6-K
INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
EX-99.2 to Form 6-K
IM Cannabis Announces CFO Departure
EX-99.1 to Form 6-K
510 Burrard Street, 3rd Floor
EX-99.1 to Form 6-K